Change in Sleep Duration and Type 2 Diabetes: The Whitehall II Study
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Evidence suggests that short and long sleep durations are associated with a higher risk of type 2 diabetes. Using successive data waves spanning >20 years, we examined whether a change in sleep duration is associated with incident diabetes. RESEARCH DESIGN AND METHODS: Sleep duration was reported at the beginning and end of four 5-year cycles: 1985–1988 to 1991–1994 (n = 5,613), 1991–1994 to 1997–1999 (n = 4,193), 1997–1999 to 2002–2004 (n = 3,840), and 2002–2004 to 2007–2009 (n = 4,195). At each cycle, change in sleep duration was calculated for participants without diabetes. Incident diabetes at the end of the subsequent 5-year period was defined using 1) fasting glucose, 2) 75-g oral glucose tolerance test, and 3) glycated hemoglobin, in conjunction with diabetes medication and self-reported doctor diagnosis. RESULTS: Compared with the reference group of persistent 7-h sleepers, an increase of ≥2 h sleep per night was associated with a higher risk of incident diabetes (odds ratio 1.65 [95% CI 1.15, 2.37]) in analyses adjusted for age, sex, employment grade, and ethnic group. This association was partially attenuated by adjustment for BMI and change in weight (1.50 [1.04, 2.16]). An increased risk of incident diabetes was also seen in persistent short sleepers (average ≤5.5 h/night; 1.35 [1.04, 1.76]), but this evidence weakened on adjustment for BMI and change in weight (1.25 [0.96, 1.63]). CONCLUSIONS: This study suggests that individuals whose sleep duration increases are at an increased risk of type 2 diabetes. Greater weight and weight gain in this group partly explain the association.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantity and Quality of Sleep and Incidence of Type 2 Diabetes
Cappuccio, F. P., D'Elia, L., Strazzullo, P., & Miller, M. A. (2010) · Diabetes Care · doi:10.2337/dc09-1124 · Cited by 1,670
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk
Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Regan, M. M., Price, N. J., Dinges, D. F., & Mullington, J. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.050 · Cited by 1,195 · cited 1×
“proinflammatory state (15), and common forms of sleep loss, such as reductions of 25–50% across consecutive nights, appear to induce an increase in levels of interleukin-6 and C-reactive protein (16,17).”
BackgroundAdverse Effects of Modest Sleep Restriction on Sleepiness, Performance, and Inflammatory Cytokines
Vgontzas, A. N., Zoumakis, E., Bixler, E. O., Lin, H.-M., Follett, H., Kales, A., & Chrousos, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031562 · Cited by 1,050 · cited 1×
“proinflammatory state (15), and common forms of sleep loss, such as reductions of 25–50% across consecutive nights, appear to induce an increase in levels of interleukin-6 and C-reactive protein (16,17).”
BackgroundSleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies
Shan, Z., Ma, H., Xie, M., Yan, P., Guo, Y., Bao, W., Rong, Y., Jackson, C. L., Hu, F. B., & Liu, L. (2015) · Diabetes Care · doi:10.2337/dc14-2073 · Cited by 902
Tabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898 · cited 1×
“Blood glucose was measured using the glucose oxidase method, as previously described (11).”
MethodSelf-citationSleep Duration as a Risk Factor for Diabetes Incidence in a Large US Sample
Gangwisch, J. E., Heymsfield, S. B., Boden-Albala, B., Buijs, R. M., Kreier, F., Pickering, T. G., Rundle, A. G., Zammit, G. K., & Malaspina, D. (2007) · Sleep · doi:10.1093/sleep/30.12.1667 · Cited by 573
Ferrie, J. E., Shipley, M. J., Cappuccio, F. P., Brunner, E., Miller, M. A., Kumari, M., & Marmot, M. G. (2007) · Sleep · doi:10.1093/sleep/30.12.1659 · Cited by 515
Self-citationCorrelates of Long Sleep Duration
Patel, S. R., Malhotra, A., Gottlieb, D. J., White, D. P., & Hu, F. B. (2006) · Sleep · doi:10.1093/sleep/29.7.881 · Cited by 490
Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes
Aronsohn, R. S., Whitmore, H., Van Cauter, E., & Tasali, E. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1423oc · Cited by 453 · cited 1×
“Sleep apnea is highly prevalent in people with type 2 diabetes (29).”
BackgroundSleep and Mortality: A Population-Based 22-Year Follow-Up Study
Hublin, C., Partinen, M., Koskenvuo, M., & Kaprio, J. (2007) · Sleep · doi:10.1093/sleep/30.10.1245 · Cited by 439
Melatonin secretion and the incidence of type 2 diabetes
McMullan, C. J., Schernhammer, E. S., Rimm, E. B., Hu, F. B., & Forman, J. P. (2013) · JAMA · doi:10.1001/jama.2013.2710 · Cited by 369 · cited 1×
“Melatonin is reduced in short sleepers, and recent work has shown lower levels of melatonin secretion to be independently associated with a higher risk of developing type 2 diabetes (19).”
BackgroundStranges, S., Dorn, J. M., Shipley, M. J., Kandala, N.-B., Trevisan, M., Miller, M. A., Donahue, R. P., Hovey, K. M., Ferrie, J. E., Marmot, M. G., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn337 · Cited by 344
Self-citationThe metabolic burden of sleep loss
Schmid, S. M., Hallschmid, M., & Schultes, B. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70012-9 · Cited by 328 · cited 2×
“There are a number of potential mechanisms through which short sleep may affect glucose metabolism (4).”
BackgroundWANG, X., BI, Y., ZHANG, Q., & PAN, F. (2013) · Respirology · doi:10.1111/j.1440-1843.2012.02267.x · Cited by 234 · cited 1×
“for example, is a cause of increased need for sleep, and moderate to severe apnea is also associatedwith an increased risk of type 2 diabetes (22).”
BackgroundEverson, C. A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00021.2005 · Cited by 141 · cited 1×
“proinflammatory state (15), and common forms of sleep loss, such as reductions of 25–50% across consecutive nights, appear to induce an increase in levels of interleukin-6 and C-reactive protein (16,17).”
BackgroundSleep disturbances and insulin resistance
Van Cauter, E. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03459.x · Cited by 97
Cited by
The links between sleep duration, obesity and type 2 diabetes mellitus
Antza, C., Kostopoulos, G., Mostafa, S., Nirantharakumar, K., & Tahrani, A. (2022) · Journal of Endocrinology · doi:10.1530/joe-21-0155 · Cited by 279
Bermúdez-Millán, A., Pérez-Escamilla, R., Segura-Pérez, S., Damio, G., Chhabra, J., Osborn, C. Y., & Wagner, J. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.231365 · Cited by 59
Sleep, circadian dysrhythmia, obesity and diabetes
Sridhar, G. R., & Sanjana, N. S. N. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i19.515 · Cited by 44
Lu, Y., Sugawara, Y., Zhang, S., Tomata, Y., & Tsuji, I. (2018) · Sleep · doi:10.1093/sleep/zsy143 · Cited by 40
Metadata
- Authors
- Ferrie, J. E., Kivimäki, M., Akbaraly, T. N., Tabak, A., Abell, J., Davey Smith, G., Virtanen, M., Kumari, M., & Shipley, M. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-06-11
- Volume
- 38
- Issue
- 8
- Pages
- 1467-1472
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2126085827
- Cited by
- 77
- References
- 16
- FWCI
- 15.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.